Record Display for the EPA National Library Catalog

RECORD NUMBER: 439 OF 1140

Main Title Evaluation of the potential carcinogenicity of aziridine (151-56-4) /
CORP Author Syracuse Research Corp., NY. ;Environmental Monitoring and Services, Inc., Washington, DC.;Environmental Protection Agency, Washington, DC. Office of Health and Environmental Assessment.
Publisher U.S. Environmental Protection Agency, Office of Emergency and Remedial Response ;
Year Published 1988
Report Number EPA/600/8-91/068; EPA-68-03-3112; EPA-68-03-3182
Stock Number PB93-184919
Subjects Aromatic compounds--Carcinogenicity ; Aziridine--Carcinogenicity
Additional Subjects Aziridines ; Toxicity ; Risk assessment ; Public health ; Exposure ; Neoplasms ; Hazardous materials ; Tolerances(Physiology) ; Carcinogenicity ; Dose-response relationships ; CAS Registry No: 151-56-4
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
NTIS  PB93-184919 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation 17 pages ; 28 cm
Abstract
Aziridine is a probable human carcinogen, classified as weight-of-evidence Group B2 under the EPA Guidelines for Carcinogen Risk Assessment. Evidence on potential carcinogenicity from animal studies is 'Sufficient', and the evidence from human studies is 'No Data'. The potency factor (F) for aziridine is estimated to be 336 (mg/kg/day)(-1), placing it in potency group 1 according to the CAG's methodology for evaluating potential carcinogens. Combining the weight-of-evidence group and the potency group, aziridine is assigned a 'HIGH' hazard ranking for the purposes of RQ adjustment.
Notes
Cover title. "June 1988." Includes bibliographical references. Microfiche.